Literature DB >> 16941223

Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.

Harm H H Feringa1, Don Poldermans, Patrick Klein, Jerry Braun, Robert J M Klautz, Ron T van Domburg, Arnoud van der Laarse, Ernst E van der Wall, Robert A E Dion, Jeroen J Bax.   

Abstract

BACKGROUND AND AIM: N-terminal pro-B-type natriuretic peptide (NT-proBNP) has diagnostic and prognostic value in patients with heart failure. The present prospective study was designed to assess whether changes in NT-proBNP levels after surgical mitral valve repair reflect changes in heart failure symptoms and changes in left atrial size, left ventricular size and left ventricular function.
METHODS: The study population consisted of 22 patients (mean age: 62.8 +/- 14.2 years, 68% male) undergoing surgical mitral valve repair. Serial NT-proBNP measurements, transthoracic echocardiography and New York Heart Association (NYHA) class assessment were performed before and 6 months after surgery.
RESULTS: All patients underwent successful mitral valve repair and no patients died during follow-up. The decrease in NT-proBNP level was associated with the reduction in left atrial dimension (r = 0.72, P < 0.001), left ventricular end-systolic dimension (r = 0.63, P = 0.002), left ventricular end-diastolic dimension (r = 0.46, P = 0.031), and the increase in fractional shortening (r = - 0.63, P = 0.002). Finally, patients with decreasing NT-proBNP levels revealed a significant improvement in heart failure symptoms (NYHA class).
CONCLUSION: Changes in NT-proBNP after surgical mitral valve repair reflect changes in heart failure symptoms and changes in left atrial and ventricular dimensions and function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941223     DOI: 10.1007/s10554-006-9138-z

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  14 in total

1.  Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay.

Authors:  Kiang-Teck J Yeo; Alan H B Wu; Fred S Apple; Martin H Kroll; Robert H Christenson; Kent B Lewandrowski; Frank A Sedor; Anthony W Butch
Journal:  Clin Chim Acta       Date:  2003-12       Impact factor: 3.786

Review 2.  Natriuretic peptides.

Authors:  E R Levin; D G Gardner; W K Samson
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

3.  Relationship of extent and nature of dysfunctional myocardium to brain natriuretic peptide in patients with ischemic left ventricular dysfunction.

Authors:  Charles A Nelson; Colin Case; Jane McCrohon; Thomas H Marwick
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

4.  B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome.

Authors:  Delphine Detaint; David Messika-Zeitoun; Jean-François Avierinos; Christopher Scott; Horng Chen; John C Burnett; Maurice Enriquez-Sarano
Journal:  Circulation       Date:  2005-05-10       Impact factor: 29.690

5.  Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation.

Authors:  C I Brookes; M W Kemp; J Hooper; P J Oldershaw; N E Moat
Journal:  J Heart Valve Dis       Date:  1997-11

6.  Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation.

Authors:  Susan A Mayer; James A De Lemos; Sabina A Murphy; Sandra Brooks; Brad J Roberts; Paul A Grayburn
Journal:  Am J Cardiol       Date:  2004-04-15       Impact factor: 2.778

7.  Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.

Authors:  John G Lainchbury; Elizabeth Campbell; Christopher M Frampton; Timothy G Yandle; M Gary Nicholls; A Mark Richards
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

8.  N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

Authors:  Paulo Bettencourt; Ana Azevedo; Joana Pimenta; Fernando Friões; Susana Ferreira; António Ferreira
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

9.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

Review 10.  Essential biochemistry and physiology of (NT-pro)BNP.

Authors:  Christian Hall
Journal:  Eur J Heart Fail       Date:  2004-03-15       Impact factor: 15.534

View more
  4 in total

1.  Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.

Authors:  Sakir Arslan; Mustafa Kemal Erol; Engin Bozkurt; Mahmut Acikel; Fuat Gundogdu; Sebahattin Atesal; Huseyin Senocak
Journal:  Int J Cardiovasc Imaging       Date:  2006-12-14       Impact factor: 2.357

2.  The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis.

Authors:  Namik Kemal Eryol; Ali Dogan; Ibrahim Ozdogru; Mehmet Tugrul Inanc; Mehmet Gungor Kaya; Nihat Kalay
Journal:  Int J Cardiovasc Imaging       Date:  2006-12-21       Impact factor: 2.357

3.  Dynamics of the liver stiffness value using transient elastography during the perioperative period in patients with valvular heart disease.

Authors:  Young Eun Chon; Seung Up Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Sak Lee
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

4.  Pulmonary capillary wedge pressure and natriuretic peptide levels in patients with sinus rhythm and severe left atrial enlargement following mitral valve surgery: early and late changes.

Authors:  S Hyllén; S Nozohoor; C Meurling; P Wierup; J Sjögren
Journal:  Heart Lung Vessel       Date:  2015
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.